Single Cell Discoveries receives first Illumina NovaSeq X Plus in the Benelux

Mauro Muraro, CEO of Single Cell Discoveries, expresses his enthusiasm for the delivery, stating, "We are thrilled to incorporate the Illumina NovaSeq X Plus sequencing system into our advanced infrastructure. This occasion underscores our dedication to providing our clients with the most innovative tools and services available in the single-cell field. With the NovaSeq X Plus system, we are now better equipped than ever to secure fast turnaround times and excellent quality throughout the single-cell workflow."

Mauro Muraro, CEO of Single Cell Discoveries, expresses his enthusiasm for the delivery, stating, "We are thrilled to incorporate the Illumina NovaSeq X Plus sequencing system into our advanced infrastructure. This occasion underscores our dedication to providing our clients with the most innovative tools and services available in the single-cell field. With the NovaSeq X Plus system, we are now better equipped than ever to secure fast turnaround times and excellent quality throughout the single-cell workflow."

 "Our NovaSeq X series can deliver 2.5x greater throughput while also driving down sequencing costs," said Bas Verhoef, Head of Europe, Illumina. "Our revolutionary technology can strengthen Single Cell Discoveries' ability to provide rapid turnaround times and processing of large sample volumes."

Single Cell Discoveries' investment in the Illumina NovaSeq X Plus sequencing system exemplifies their ongoing commitment to pushing the boundaries of single-cell sequencing. By harnessing the power of this state-of-the-art technology, Single Cell Discoveries aims to accelerate the development of precision medicine, contribute to the understanding of complex diseases, and foster groundbreaking research initiatives across Europe and beyond.

About Single Cell Discoveries

Single Cell Discoveries is a CRO dedicated to single-cell sequencing, providing high-impact insights to biopharmaceutical companies, health systems, and academic research centers globally. It was founded in 2018 by Mauro Muraro, PhD, and Judith Vivié, MSc, and is based in Utrecht, the Netherlands. To learn more, visit our website and connect with us on LinkedIn and Twitter.

Logo - https://mma.prnewswire.com/media/1605430/Single_Cell_Discoveries_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/single-cell-discoveries-receives-first-illumina-novaseq-x-plus-in-the-benelux-301844205.html